Hematology & Medical Oncology Fellowship Training Program Leadership
We take great pride in NYU Grossman School of Medicine’s Hematology and Medical Oncology Fellowship, and we are pleased that you are interested in learning more about our curriculum and educational opportunities. The decision to pursue a career in hematology or medical oncology represents a major commitment to your professional goals and to serving patients in the heart of New York City.
Our fellows play a central role in providing outstanding care to our diverse patient population through NYU Langone’s Department of Medicine and Perlmutter Cancer Center, where a broad range of clinical, basic, and translational research projects are available. Our program has a long history of training leaders in academic hematology and medical oncology. An integral part of the training program is broad-based exposure at three patient care locations: NYU Langone’s Tisch Hospital, NYC Health + Hospitals/Bellevue, and VA NY Harbor Healthcare System.
Our diverse faculty is dedicated to training our fellows in the art and science of this exciting field of medicine. Our cancer center has been invigorated with new leadership and continues to grow with the recruitment of highly renowned faculty who specialize in treating various disease types. We continue to focus on clinical excellence, new research laboratories, and finding better therapies for our most devastating diseases.
As you learn about our program, feel free to contact us with any questions. We look forward to hearing from you.
The Hematology and Medical Oncology Fellowship leadership team provides expertise and mentorship to our fellows.
Shella Saint Fleur-Lominy, MD, PhD, Director of the Hematology and Medical Oncology Training Program
Dr. Saint Fleur-Lominy’s personal experience with the fellowship builds upon Dr. Grossbard’s strides in creating an excellent fellowship program.
Michael L. Grossbard MD, Associate Director of the Hematology and Medical Oncology Fellowship Training Program
Dr. Grossbard continues the fellowship’s long history of excellent general clinical training, emphasizing the subspecialty research and clinical training components of the program. Learn more about Dr. Grossbard.
Benjamin G. Neel, MD, PhD, Director of Perlmutter Cancer Center
In addition to his leadership role at Perlmutter Cancer Center, Dr. Neel is a professor in the Department of Medicine. His research focuses on cellular signaling, with a particular emphasis on the biology and regulation of protein tyrosine kinases and phosphatases, the role of RAS/ERK pathway mutations in developmental disease and malignancy, and the biology of breast and ovarian cancer. Learn more about Dr. Neel.
Kwok-Kin Wong, MD, PhD, Director of the Division of Hematology and Medical Oncology
Dr. Wong’s research, teaching, and clinical activities focus on understanding the pathogenesis and genetic alterations involved in the formation and growth of lung tumors and testing novel targeted cancer therapeutics in vivo in lung cancers. Dr. Wong’s laboratory integrates human cancer genomic studies, the generation of de novo mouse models of cancer, and novel drug treatment studies. The hope is that these studies, using genetically engineered mouse cancer models, may provide insights that lead to curative combination regimens for patients with advanced lung cancer. Learn more about Dr. Wong.
Ivelisse Montalvo, MPA, Administrator of the Division of Hematology and Medical Oncology, and Senior Fellowship Program Coordinator of the Division of Hematology and Medical Oncology Fellowship
Mrs. Montalvo works with the division’s fellowship program and collaborates with program leadership to maintain accreditation, generate faculty engagement, and implement quality improvements.
Mrs. Montalvo works closely with the program director, faculty, and fellows to improve the program’s processes.
Wendy Guerrier, Fellowship Program Coordinator of the Division of Hematology and Medical Oncology Fellowship
Ms. Guerrier works closely with the program director, faculty, and fellows to improve the program’s processes.